ALOPECIA AREATA
Clinical trials for ALOPECIA AREATA explained in plain language.
Never miss a new study
Get alerted when new ALOPECIA AREATA trials appear
Sign up with your email to follow new studies for ALOPECIA AREATA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Pill shows promise for regrowing hair in major alopecia trial
Disease control CompletedThis study tested whether baricitinib, a pill taken daily, could help regrow hair in adults with severe alopecia areata, an autoimmune condition causing significant hair loss. Over 760 participants were randomly assigned to receive either a low dose, a high dose, or a placebo pil…
Matched conditions: ALOPECIA AREATA
Phase: PHASE2, PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC
-
Hair regrowth breakthrough? experimental injection shows promise for bald spots
Disease control CompletedThis study tested whether low-dose injections of a medication called IL-2 could help regrow hair in adults with severe alopecia areata, an autoimmune condition causing patchy or total hair loss. Participants had lost at least 50% of scalp hair and hadn't improved with other treat…
Matched conditions: ALOPECIA AREATA
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Pill vs injection: new hope for hair regrowth?
Disease control CompletedThis completed study tested whether a daily pill (roflumilast) works as well as steroid injections for treating patchy hair loss from alopecia areata. It involved 50 adults with mild to moderate hair loss over 16 weeks. The goal was to see which treatment helped hair grow back be…
Matched conditions: ALOPECIA AREATA
Phase: PHASE4 • Sponsor: Cairo University • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Drug trial aims to calm overactive immune system in down syndrome
Disease control CompletedThis study tested whether the drug tofacitinib is safe and effective for treating several common autoimmune skin conditions in adolescents and adults with Down syndrome. Researchers wanted to see if reducing overactive immune signaling could improve skin health, quality of life, …
Matched conditions: ALOPECIA AREATA
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Hair regrowth drug shows promise in Long-Term study
Disease control CompletedThis study followed adults with moderate to severe alopecia areata, an autoimmune condition causing hair loss, to see how safe and effective the drug CTP-543 is over a long period. It was an extension study for 407 people who had already taken the drug in a previous trial. The ma…
Matched conditions: ALOPECIA AREATA
Phase: PHASE3 • Sponsor: Sun Pharmaceutical Industries, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
Glowing clothes tested to fight skin disease
Disease control CompletedThis study tested a special fabric called Lumiton that converts sunlight into therapeutic red and near-infrared light. It aimed to see if wearing clothes made from this fabric could help control symptoms of psoriasis, alopecia areata (hair loss), and polymorphous light eruption (…
Matched conditions: ALOPECIA AREATA
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Scientists search for genetic clue behind hair loss condition
Knowledge-focused CompletedThis study aimed to understand if a specific variation in a gene called TLR7 is linked to developing alopecia areata, an autoimmune hair loss condition. Researchers compared the genes of 120 people—some with alopecia and some without—to see if the gene variation was more common i…
Matched conditions: ALOPECIA AREATA
Sponsor: Benha University • Aim: Knowledge-focused
Last updated Apr 01, 2026 21:40 UTC